Evidence map›Paper›PMID 32295501›Full record

ArticleJournal of psychoactive drugs

Associations between Psychiatric Disorders and Cannabis-Related Disorders Documented in Electronic Health Records.

Anne Campbell, Steffani R Bailey, Kim A Hoffman, Javier Ponce-Terashima, Katie Fankhauser, Miguel Marino, Dennis McCarty

Open access · greenAbstract read
In one paragraph

Article in Journal of psychoactive drugs. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 3 countries.

Anne CampbellSchool of Social Sciences, Education and Social Work, Queens University , Belfast, ME, UK.
Steffani R BaileyDepartment of Family Medicine, Oregon Health & Science University , Portland, OR, USA.
Kim A HoffmanOregon Health & Science University-Portland State University School of Public Health , Portland, Oregon, OR, USA.ORCID 0000-0003-3063-7881
Javier Ponce-TerashimaCase Western University-University Hospitals , Cleveland, OH, USA.
Katie FankhauserDepartment of Family Medicine, Oregon Health & Science University , Portland, OR, USA.ORCID 0000-0003-2381-7796
Miguel MarinoDepartment of Family Medicine, Oregon Health & Science University , Portland, OR, USA.
Dennis McCartyOregon Health & Science University-Portland State University School of Public Health , Portland, Oregon, OR, USA.
Portland State University · USOregon Health & Science University · USQueen's University Belfast · GBUniversity Hospitals of Cleveland · US

Funding

Western States Node of the National Drug Abuse Treatment Clinical Trials Network (TMS for CUD) UG1DA015815 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Keith N. Humphreys, Philip Todd Korthuis · 2015 to 2026
$24.6M
Meaningful Use and Treatment of Smoking in Federally-Qualified Health CentersK23DA037453 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI BAILEY, STEFFANI R · 2015 to 2019
$841k
NIDA NIH HHS K23 DA037453NIDA NIH HHS UG1 DA015815
6 · The paper itself

Abstract

Data from a large network of community health centers connected via a single electronic health record (EHR) system examined associations between psychiatric disorders and documentation of a cannabis-related disorder among patients with reported cannabis use. Participants were adults who had at least one ambulatory visit at a clinic in three states between 1/1/2012 and 12/31/2016 and had either 1) a documented cannabis-related disorder indicated by an ICD-9/10 code on the problem list or encounter list or 2) documentation of cannabis use in the EHR social history section. Clinics included 101,405 patients with either cannabis use recorded in the social history of the EHR (n = 71,660) or a cannabis-related disorder documented in the encounter or problem list (n = 29,745). GEE logistic regression modeling estimated adjusted odds ratios (aOR). Odds of patients having cannabis-related disorder recorded on the encounter or problem list were higher for individuals with depression (aOR = 1.08, 95% CI: 1.04-1.13), anxiety (aOR = 1.16, CI: 1.11-1.21) and bipolar disorder (aOR = 1.16, CI: 1.10-1.23). A diagnosis of schizophrenia increased the odds of a cannabis-related disorder by 62% (aOR = 1.62, CI: 1.48- 1.78). Primary care providers should routinely screen for and document cannabis-related disorders and psychiatric disorders.

Indexed as

AdolescentAdultAgedAmbulatory CareCaliforniaElectronic Health RecordsFemaleHealth SurveysHumansMaleMarijuana AbuseMental DisordersMiddle AgedOdds RatioOregonRisk Factorscannabis use disorderelectronic health recordspsychiatric disordersSubstance use disorder

Identifiers

PMID32295501
PMCPMC7671705
OpenAlexW3016319481

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.